Clinical Trials Browser

Hemangiosarcoma × durvalumab × 90 days × Clear all

Hemangiosarcoma, Liposarcoma, Osteosarcoma

Pathologic Complete Response, Breast Neoplasms, Hemangiosarcoma, Neoplasms, Triple Negative Breast Neoplasms